ASMI warns of challenges to new advertising complaints handling system
The Australian Self Medication Industry (ASMI) today stated its
support to assign
a single body to handle complaints about the advertising of medicines and medical devices to the public, however ASMI CEO Deon Schoombie warns that "the devil is in the detail".
This follows the announcement yesterday that the TGA will take on sole responsibility for handling consumer advertising complaints from 1 July 2018 in order to "simplify and improve" the process.
"We are happy with the direction that the complaints handling is going, however ASMI remains concerned about the removal of pre-approvals prior to the effectiveness of new measures being demonstrated," says Mr Schoombie.
The TGA has taken a step in the right direction to streamline the complaints handling process in order to help deliver consistent decision-making, compliance and enforcement.
"We look forward to working with the TGA to develop the details of both the new scheme and the transition arrangements," says Mr Schoombie.
"It is crucial that there is timely, transparent consideration of complaints using the relevant expertise.
"Following evaluation of the three-year trial and the subsequent external review, we would also consider the TGA taking on advertising to healthcare professionals as well," says Mr Schoombie.